参考文献/References:
[1] Wesley UV,Sutton IC,Cunningham K,et al.Galectin-3 protects against ischemic stroke by promoting neuro-angiogenesis via apoptosis inhibition and Akt/Caspase regulation[J].Journal Cereb Blood Flow Metab,2021,41(6):857-873.
[2] 胡跃强,唐 农,董少龙,等.清热化瘀方预处理对大鼠脑缺血再灌注损伤的神经保护作用[J].中国实验方剂学杂志,2012,18(4):194-197.
[3] 胡跃强,陈 炜,祝美珍,等.清热化瘀方通过调控自噬相关基因P62/LC3保护大鼠脑缺血再灌注损伤[J].陕西中医,2020,41(4):429-433.
[4] 韦 辰,王士雷,孔宪刚,等.补阳还五汤对脑缺血再灌注损伤大鼠线粒体分裂蛋白Drp1、Fis1及细胞色素C表达的影响[J].陕西中医,2017,38(10):1481-1483.
[5] Cheng X,Hu J,Liu X,et al.Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases[J].Front Pharmacol,2022,19(13):934-942.
[6] Han YL,Li XW,Yang L,et al.Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice[J].Journal Ginseng Res,2022,46(11):515-525.
[7] 刘体勤,刘春柳,陈 燕,等.莫雪妮运用“扶阳思想”次第治疗中风病探微[J].陕西中医,2019,40(7):934-936.
[8] 胡跃强.基于扶阳学术思想论新型冠状病毒肺炎三焦次第治疗[J].辽宁中医药大学学报,2020,22(10):8-11.
[9] Borsello T,Clarke GH,Hirt L,et al.A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia[J].Nat Med,2003,9(10):1180-1186.
[10] 胡跃强,唐 农,胡玉英,等.温阳复元方联合西药治疗缺血性中风恢复期患者109例临床观察[J].中医杂志,2017,58(18):1569-1572.
[11] 刘 佩,刘玥彤,杨鎏鑫,等.基于网络药理学和GEO数据研究三七、黄芪和丹参防治缺血性脑卒中作用机制[J].右江民族医学院学报,2022,44(1):43-52.
[12] Ghafouri FS,Abak A,Mohaqiq M,et al.Interaction between non-coding RNAs and JNK in human disorders[J].Biomed Pharmacother,2021,138(18):111-123.
[13] Shvedova M,Anfinogenova Y,Atochina VN,et al.c-Jun N-Terminal kinases in myocardial and cerebral ischemia/reperfusion injury[J].Front Pharmacol,2018,9(21):715-726.
[14] 田俊斌,赵 静,吕建瑞,等.丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路在穿心莲内酯治疗心肌缺血/再灌注损伤大鼠中的分子机制[J].陕西中医,2022,43(5):575-579.
[15] 王 月,刘佳俊,王 雷,等.缺血后处理通过升高血清腺苷水平减轻脑缺血再灌注损伤的实验研究[J].陕西医学杂志,2021,50(7):789-792.
[16] 张霞婧,毛肖肖,朱芳芸,等.丙酮酸乙酯通过调控小胶质细胞极化减轻脑缺血再灌注损伤实验研究[J].陕西医学杂志,2022,51(5):520-524.
[17] 朱美霖,白宏英.Purmorphamine对脑缺血再灌注大鼠细胞凋亡影响的实验研究[J].陕西医学杂志,2021,50(1):7-9,21.
[18] 高 静,边步荣,高彦东,等.茶氨酸处理脑缺血后大鼠海马血红素加氧酶-1表达及细胞凋亡的影响研究[J].陕西医学杂志,2019,48(7):823-826,841.
[19] 种 莉,陈 丽,张李娜,等.缺血预处理和缺血后处理对脑缺血再灌注损伤保护作用的实验研究[J].陕西医学杂志,2017,46(10):1360-1362.
[20] 胡跃强,唐 农,秦红玲,等.P62通过调控自噬与抗氧化通路保护大鼠脑缺血再灌注损伤[J].中华老年心脑血管病杂志,2019,21(3):304-308.
相似文献/References:
[1]朱慧渊,党珊,万海同,等.基于方剂配伍理论的中药有效组分配伍抗脑缺血再灌注损伤作用原理探讨[J].陕西中医,2016,(10):1388.
[2]耿银龙,张伟萍,任梦诗.温阳复元方对缺血性脑卒中患者运动功能及生存质量影响研究*[J].陕西中医,2020,(2):172.
GENG Yinlong,ZHANG Weiping,REN Mengshi..Effect of Wenyang Fuyuan decoction on motor function and quality of life in patients with ischemic stroke[J].,2020,(3):172.
[3]李丽琴,张 鼎,袁 莉,等.温阳复元方联合miR-137模拟剂调控线粒体铁死亡对脑缺血再灌注损伤大鼠的作用机制[J].陕西中医,2023,(10):1354.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.005]
LI Liqin,ZHANG Ding,YUAN Li,et al.Effect mechanism of Wenyang Fuyuan formula combined with miR-137 mimic to regulate mitochondrial iron death in rats with cerebral ischemia-reperfusion injury[J].,2023,(3):1354.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.005]